-
Loading metrics
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype
- Alejandro J. Español,
- Agustina Salem,
- María Di Bari,
- Ilaria Cristofaro,
- Yamila Sanchez,
- Ada M. Tata,
- María E. Sales
x
- Published: September 10, 2020
- https://doi.org/10.1371/journal.pone.0226450